- 関
- anti-tumor immune response
WordNet
- secure against; "immune from taxation as long as he resided in Bermuda"; "immune from criminal prosecution"
- a person who is immune to a particular infection
- relating to or conferring immunity (to disease or infection) (同)resistant
- (usually followed by `to'
- relating to the condition of immunity; "the immune system"
- a result; "this situation developed in response to events in Africa"
- a phrase recited or sung by the congregation following a versicle by the priest or minister
- the manner in which an electrical or mechanical device responds to an input signal or a range of input signals
PrepTutorEJDIC
- 免疫の / 《補語にのみ用いて》(影響・攻撃・義務・税などを)免れている《+『against』(『from, to』)+『名』》
- 〈C〉(…に対する)『返事』,『返答』《+『to』+『名』》 / 〈C〉〈U〉(…に対する)『反応』,『反響』《『to』+『名』》 / 〈C〉応答歌,応唱(牧師にならって合唱隊・会衆が短い祈り・歌を応答すること)
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Antitumor effects obtained by autologous Lewis lung cancer cell vaccine engineered to secrete mouse Interleukin 27 by means of cationic liposome.
- Zhang J, Tian H, Li C, Cheng L, Zhang S, Zhang X, Wang R, Xu F, Dai L, Shi G, Chen X, Li Y, Du T, Deng J, Liu Y, Yang Y, Wei Y, Deng H.SourceState Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, People's Republic of China.
- Molecular immunology.Mol Immunol.2013 Oct;55(3-4):264-74. doi: 10.1016/j.molimm.2013.02.006. Epub 2013 Mar 21.
- Interleukin-27 (IL-27), a novel IL-6/IL-12 family cytokine, plays an important role in the early regulation of Th1 responses. The cytokine IL-27 can exert a variety of immune-regulatory functions including cytotoxic T lymphocyte (CTL), CD4(+), CD8+ T lymphocytes activation and interferon-γ (IFN-γ)
- PMID 23522926
- Targeting the EP1 receptor reduces Fas ligand expression and increases the antitumor immune response in an in vivo model of colon cancer.
- O'Callaghan G, Ryan A, Neary P, O'Mahony C, Shanahan F, Houston A.SourceDepartment of Medicine, University College Cork, Cork, Ireland.
- International journal of cancer. Journal international du cancer.Int J Cancer.2013 Aug 15;133(4):825-34. doi: 10.1002/ijc.28076. Epub 2013 Mar 4.
- Despite studies demonstrating that inhibition of cyclooxygenase-2 (COX-2)-derived prostaglandin E2 (PGE2 ) has significant chemotherapeutic benefits in vitro and in vivo, inhibition of COX enzymes is associated with serious gastrointestinal and cardiovascular side effects, limiting the clinical util
- PMID 23390011
- Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice.
- Masuda Y, Inoue H, Ohta H, Miyake A, Konishi M, Nanba H.SourceDepartment of Microbial Chemistry, Kobe Pharmaceutical University, 4-19-1, Motoyama-kitamachi, Higashinada-ku, Kobe, 658-8558, Japan. organic@kobepharma-u.ac.jp
- International journal of cancer. Journal international du cancer.Int J Cancer.2013 Jul;133(1):108-19. doi: 10.1002/ijc.27999. Epub 2013 Feb 15.
- Maitake D (MD)-Fraction is a highly purified soluble β-glucan derived from Grifola frondosa (an oriental edible mushroom). Intraperitoneal (i.p.) injection of MD-Fraction has been reported to inhibit tumor growth via enhancement of the host immune system. In this study, we demonstrated that oral ad
- PMID 23280601
Japanese Journal
- ATM-Mediated DNA Damage Signals Mediate Immune Escape through Integrin-αvβ3-Dependent Mechanisms
- Jinushi Masahisa,Chiba Shigeki,Baghdadi Muhammad,Kinoshita Ichiro,Dosaka-Akita Hirotoshi,Ito Koyu,Yoshiyama Hironori,Yagita Hideo,Uede Toshimitsu,Takaoka Akinori
- Cancer Research 72(1), 56-65, 2012-01-01
- … We identified a novel mechanism whereby constitutively activated DNA damage signals in anticancer therapy-resistant tumor cells suppress antitumor immunity in an integrin-αvβ3-dependent manner. … The inhibition of tumor-specific integrin-αvβ3 improved therapeutic efficacies of anticancer drugs by stimulating endogenous host immune systems. …
- NAID 120005090590
- 田中 康広
- 耳鼻咽喉科免疫アレルギー 30(1), 1-7, 2012
- 近年,樹状細胞を用いた悪性腫瘍に対する免疫療法は特に注目を集めており,腫瘍抗原特異的な抗腫瘍効果の誘導を目指した臨床試験が世界各国のさまざまな施設で行われてきた。樹状細胞は生体内において最も強力な抗原提示細胞であり,T細胞を中心とした免疫担当細胞を調節し,腫瘍特異的な免疫反応を誘導するうえで重要な存在だと言える。この樹状細胞を用いた免疫療法は1996年に悪性リンパ腫に対して初めて臨床試験が行われ, …
- NAID 130002152163
- 免疫応答に関する確率モデルについて : 腫瘍免疫応答のモデル化に向けて (第7回生物数学の理論とその応用)
Related Links
- Communication between the immune system and tumor cells takes place via both cell-cell contact-dependent receptor-ligand interactions and released cytokines/chemokines. T lymphocytes of the adaptive immune system learn in ...
- Learn how the body’s antitumor immune response can detect and destroy tumor cells. ... Some tumor cells can evade the body’s immune response, which may result in disease progression 1,2 One function of the body's immune ...
Related Pictures
★リンクテーブル★
[★]
- 英
- antitumor immune response、anti-tumor immune response
- 関
- 抗腫瘍免疫応答
[★]
- 英
- antitumor immune response、anti-tumor immune response
- 関
- 抗腫瘍免疫反応
[★]
- 関
- antitumor immune response
[★]
- 関
- anti-tumor、anticancer、antitumoral、antitumorigenic、antitumour、carcinostatic
[★]
- 関
- immunisation、immunise、immunity、immunization、immunize、immuno、immunologic
[★]